Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells

Surgery

Volumn 149, Issue 6, 2011, Pages 792-800

  Takemoto, Yoshihiro ^a   Li, Tao Sheng ^a   Kubo, Masayuki ^a   Ohshima, Mako ^a   Ueda, Kazuhiro ^a   Harada, Eijirou ^a   Enoki, Tadahiko ^a   Okamoto, Mariko ^b   Mizukami, Yoichi ^b   Murata, Tomoaki ^b   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; PLERIXAFOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; GASTROTOMY; HEMATOPOIETIC STEM CELL; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL MOBILIZATION; SURGICAL INJURY; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

ANIMALS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STOMACH;

EID: 79957709003     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.02.005     Document Type: Article

References (28)

1. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991;214:107-13.
2. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Saiki I, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003;133:547-55. (Pubitemid 36638227)
3. Shiromizu A, Suematsu T, Yamaguchi K, Shiraishi N, Adachi Y, Kitano S. Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery 2000;128:799-805.
4. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003;10:972-92.
5. Li TS, Kaneda Y, Ueda K, Hamano K, Zempo N, Esato K. The influence of tumour resection on angiostatin levels and tumour growth - an experimental study in tumour-bearing mice. Eur J Cancer 2001;37:2283-8. (Pubitemid 33001301)
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Isner JM, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. (Pubitemid 27087709)
7. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Storb RF, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-7. (Pubitemid 28323695)
8. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Hicklin D, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201. (Pubitemid 33063774)
9. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Benezra R, et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003;4:277-89. (Pubitemid 37329792)
10. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Esato K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesisin patients with ischemic heart disease clinical trial and preliminary results. Jpn Circ J 2001;65:845-7.
11. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209. (Pubitemid 44427444)
12. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Hicklin D, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7. (Pubitemid 41753060)
13. Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Shimokawa H, et al. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 2007;100:662-9. (Pubitemid 46594880)
14. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett 1997;407:313-9.
15. Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Hamano K, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 2009;12:1814-22.
16. Murakami J, Li TS, Ueda K, Tanaka T, Hamano K. Inhibition of accelerated tumor growth by blocking the recruitment of mobilized endothelial progenitor cells after chemotherapy. Int J Cancer 2009;124:1685-92.
17. Hirbe AC, Rubin J, Uluçkan O, Morgan EA, Weilbaecher KN, et al. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proc Natl Acad Sci U S A 2007;104:14062-7. (Pubitemid 350003335)
18. Radial N, Chan JA, Segal RA, Kung AL. CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 2006;12:6765-71. (Pubitemid 44876846)
19. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Sakai Y. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 2009;16:2645-53.
20. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Springer TA, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
21. Oberlin E, Amara A, Bachelerie F, Bessia C, Baggiolini M, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5. (Pubitemid 26299571)
22. Nagasawa T, Nakajima T, Tachibana K, Iizasa H, Bleul CC, Kishimoto T, et al. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci USA 1996;93:14726-9.
23. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901-10.
24. Lataillade JJ, Clay D, Dupuy C, Rigal S, Jasmin C, Bourin P, Le Bousse-Kerdilès MC. Chemokine SDF-1 enhances circulating CD34(+. cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000;95:756-68.
25. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Moore MA, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-60.
26. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Asahara T, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322-8. (Pubitemid 36314418)
27. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 2006;66:9054-64. (Pubitemid 44521124)
28. Wu Y, Zhao RC, Tredget EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 2010;28:905-15.